摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-fluoro-8-chloro-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid | 76425-54-2

中文名称
——
中文别名
——
英文名称
9-fluoro-8-chloro-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid
英文别名
8-chloro-6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H,-benzo[ij]quinolizine-2-carboxylic acid;8-chloro-6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid;8-chloro-7-fluoro-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid
9-fluoro-8-chloro-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid化学式
CAS
76425-54-2
化学式
C14H11ClFNO3
mdl
——
分子量
295.698
InChiKey
GCNGWTDECZJQMI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    288-291 °C
  • 沸点:
    495.5±45.0 °C(Predicted)
  • 密度:
    1.55±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    20
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    57.6
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Pyrroloquinoline and benzoquinolizine compounds and antimicrobial
    申请人:Otsuka Pharmaceutical Co., Ltd.
    公开号:US04399134A1
    公开(公告)日:1983-08-16
    A benzoheterocyclic compound of the formula (I) ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and n are as defined, and its pharmaceutically acceptable salts, processes for preparing same and antibacterial composition containing the benzoheterocyclic compound as an active ingredient and a pharmaceutically acceptable carrier are disclosed.
    一种具有以下结构的苯并杂环化合物(I)##STR1##其中R.sup.1、R.sup.2、R.sup.3和n如定义,并且其药用盐、其制备方法以及含有该苯并杂环化合物作为活性成分和药用载体的抗菌组合物被揭示。
  • Piperazinylbenzoheterocyclic compounds
    申请人:Otsuka Pharmaceutical Co., Ltd.
    公开号:US04416884A1
    公开(公告)日:1983-11-22
    A piperazinylbenzoheterocyclic compound having antimicrobial properties and represented by the formula (I) ##STR1## wherein R.sup.1 represents hydrogen or lower alkyl; R.sup.2 represents hydrogen; R.sup.3 represents hydrogen, lower alkyl, lower alkanoyl, lower alkylsulfonyl, phenylalkyl, benzoyl, p-toluenesulfonyl, a group represented by the formula ##STR2## lower alkyl substituted with one to three of halogen and hydroxy, lower alkanoyl substituted with one to seven of halogen, phenylalkyl substituted with one to three of lower alkoxy on the phenyl ring, lower alkylsulfonyl substituted with one to three of halogen, lower alkenyl or lower alkynyl; R.sup.4 represents hydrogen or halogen, and n is an integer of 0 or 1, except that when n is 0, R.sup.1 and R.sup.2 together can represent the atoms necessary to form a cyclohexane ring, and when R.sup.3 represents lower alkyl substituted with one to three of halogen and hydroxy, lower alkanoyl substituted with one to seven of halogen, phenylalkyl substituted with one to three of lower alkoxy on the phenyl ring, lower alkylsulfonyl substituted with one to three of halogen, lower alkenyl or lower alkynyl, n is 1.
    一种具有抗微生物特性的哌嗪基苯并杂环化合物,其化学式为(I)其中R.sup.1代表氢或较低的烷基;R.sup.2代表氢;R.sup.3代表氢、较低的烷基、较低的烷酰基、较低的烷基磺酰基、苯基烷基、苯甲酰基、对甲苯磺酰基,由以下化学式表示的基团其中烷基上取代有一到三个卤素和羟基,烷酰基上取代有一到七个卤素,苯基烷基上取代有一到三个较低的烷氧基,烷基磺酰基上取代有一到三个卤素,较低的烯基或较低的炔基;R.sup.4代表氢或卤素,n为0或1的整数,但当n为0时,R.sup.1和R.sup.2可以一起代表形成环己烷环所需的原子,当R.sup.3代表烷基上取代有一到三个卤素和羟基,烷酰基上取代有一到七个卤素,苯基烷基上取代有一到三个较低的烷氧基,烷基磺酰基上取代有一到三个卤素,较低的烯基或较低的炔基时,n为1。
  • Benzoheterocyclic compounds and pharmaceutical composition thereof
    申请人:Otsuka Pharmaceutical Co., Ltd.
    公开号:US04552879A1
    公开(公告)日:1985-11-12
    A benzoheterocyclic compound of the formula (I) ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and n are as defined, and its pharmaceutically acceptable salts, processes for preparing same and antibacterial composition containing the benzoheterocyclic compound as an active ingredient and a pharmaceutically acceptable carrier are disclosed.
    公开了一种公式(I)的苯并杂环化合物##STR1##其中R.sup.1,R.sup.2,R.sup.3和n如定义所述,以及其药学上可接受的盐,制备该化合物的过程和含有该苯并杂环化合物作为活性成分和药学上可接受的载体的抗菌组合物。
  • STERN, RICHARD M.
    作者:STERN, RICHARD M.
    DOI:——
    日期:——
  • STERN, R. M.
    作者:STERN, R. M.
    DOI:——
    日期:——
查看更多